Aripiprazole
Product manufactured by Remedyrepack Inc.
Indications and Purposes
| 1 Indications And Usage Anagrelide Is A Platelet Reducing Agent Indicated For The Treatment Of Thrombocythemia, Secondary To Myeloproliferative Neoplasms, To Reduce The Elevated Platelet Count And The Risk Of Thrombosis And To Ameliorate Associated Symptoms Including Thrombo-Hemorrhagic Events. (1) Schizophrenia (14.1) Acute Treatment Of Manic And Mixed Episodes Associated With Bipolar I (14.2) Adjunctive Treatment Of Major Depressive Disorder (14.3) Irritability Associated With Autistic Disorder (14.4) Treatment Of Tourette's Disorder (14.5) Aripiprazole Oral Tablets Are Indicated For The Treatment Of: Schizophrenia [See Clinical Studies (14.1) ] Acute Treatment Of Manic And Mixed Episodes Associated With Bipolar I Disorder [See Clinical Studies (14.2) ] Adjunctive Treatment Of Major Depressive Disorder [See Clinical Studies (14.3) ] Irritability Associated With Autistic Disorder [See Clinical Studies (14.4) ] Treatment Of Tourette's Disorder [See Clinical Studies (14.5) ] |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Aripiprazole |
|
ZINC1851149 |